Kinetics of systemic cytokine and brain chemokine gene expression in murine Toxoplasma infection

Journal of Parasitology

Volumn 94, Issue 6, 2008, Pages 1282-1288

  Aviles, Hernan ^a,b   Stiles, Jonathan ^c   O'Donnell, Phyllis ^b   Orshal, Julia ^b   Leid, Jeffrey ^a   Sonnenfeld, Gerald ^b   Monroy, Fernando ^a  

^a NORTHERN ARIZONA UNIVERSITY   (United States)

^b BINGHAMTON UNIVERSITY   (United States)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BRAIN; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNITY; PARASITIC DISEASE; PROTEIN; PROTOZOAN; REACTION KINETICS; RNA; RODENT;

ANIMALS; ANTIBODIES, PROTOZOAN; BRAIN; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KINETICS; MICE; MICE, INBRED C57BL; RECEPTORS, CHEMOKINE; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TOXOPLASMOSIS, CEREBRAL;

MURINAE; MUS; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 58549109229     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-1309.1     Document Type: Article

References (46)

1. ADLER, M. W., AND T. J. ROGERS. 2005. Are chemokines the third major system in the brain? Journal of Leukocyte Biology 78: 1204-1209.
2. AVILES, H. O., AND F. P. MONROY. 2001. Toxoplasma gondii: Cold stress-induced modulation of antibody responses. Experimental Parasitology 99: 89-96.
3. BACON, K., M. BAGGIOLINI, H. BROXMEYER, R. HORUK, I. LINDLEY, A. MANTOVANI, K. MAYSUSHIMA, P. MURPHY, H. NOMIYAMA, J. OPPENHEIM ET AL. 2002. Chemokine/chemokine receptor nomenclature. Journal of Interferon and Cytokine Research 22: 1067-1068.
4. BAGGIOLINI, M. 1998. Chemokines and leukocyte traffic. Nature 392: 565-568.
5. BESSIERES, M. H., S. LE BRETON, AND J. P. SEGUELA. 1992. Analysis by immunoblotting of Toxoplasma gondii exo-antigens and comparison with somatic antigens. Parasitology Research 78: 222-228.
6. BLACK, M., AND J. BOOTHROYD. 2000. Lytic cycle of Toxoplasma gondii. Microbiology and Molecular Biology Reviews 64: 607-623.
7. BRENIER-PINCHART, M., H. PELLOUX, J. SIMON, J. RICARD, J. BOSSON, AND P. AMBROISE-THOMAS. 2000. Toxoplasma gondii induces the secretion of monocyte chemotactic protein-1 in human fibroblast, in vitro. Molecular and Cellular Biochemistry 209: 79-87.
8. -, D. DEROUICH-GUERGOUR, AND P. AMBROISE- THOMAS. 2001. Chemokines in host-protozoan-parasite interactions Trends in Parasitology 17: 292-296.
9. -, I. VIGAN, E. JOUVIN-MARCHE, P. N. MARCHE, E. PELET, U. GROSS, P. AMBROISE- THOMAS, AND H. PELLOUX. 2002. Monocyte chemotactic protein-1 secretion and expression after Toxoplasma gondii infection in vitro depend on the stage of the parasite. FEMS Microbiology Letters 214: 45-49.
10. -, I. VILLENA, C. MERCIER, F. DURAND, J. SIMON, M. F. CESBRON-DELAUW, AND H. PELLOUX. 2006. The Toxoplasma surface protein SAG1 triggers efficient in vitro secretion of chemokine ligand 2 (CCL2) from human fibroblasts. Microbes and Infection 8: 254-261.
11. + T cells determine cyst number in Toxoplasma gondii infection. Journal of Immunology 145: 3438-3441.
12. -, AND -. 1994. Mechanisms of survival of mice during acute and chronic Toxoplasma gondii infection. Parasitology Today 10: 290-292.
13. DECKERT-SCHLÜTER, M., A. RANG, D. WEINER, S. HUANG, O. D. WIESTLER, H. HOF, AND D. SCHLÜTER. 1996. Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Laboratory Investigation 75: 827-841.
14. DENKERS, E. Y., AND R. T. GAZZINELLI. 1998. Regulation and function of T-cell mediated immunity during Toxoplasma gondii infection. Clinical Microbiology Reviews 11: 569-588.
15. -, B. BUTCHER, L. DEL RIO, AND S. BENNOUNA. 2004. Neutrophils, dendritic cells and Toxoplasma. International Journal for Parasitology 34: 411-421.
16. DENNEY, C., L. ECKMANN, AND L. REED. 1999. Chemokine secretion of human cells in response to Toxoplasma gondii infection. Infection and Immunity 67: 1547-1552.
17. DIANA, J., C. VINCENT, F. PEYRON, S. PICOT, D. SCHMITT, AND F. PERSAT. 2005. Toxoplasma gondii regulates recruitment and migration of human dendritic cells via different soluble secreted factors. Clinical and Experimental Immunology 141: 475-484.
18. DI CRISTINA, M., P. DEL PORTO, W. BUFFOLANO, E. BEGHETTO, A. SPADONI, S. GUGLIETTA, E. PICCOLELLA, F. FELICI, AND N. GARGANO. 2004. The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection. Microbes and Infection 6: 164-171.
19. DUBEY, J. P. 1994. Toxoplasmosis. Journal of the American Veterinary Medical Association 205: 1593-1598.
20. + T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. Journal of Immunology 146: 286-292.
21. -, M. WYSOCKA, S. HAYASHI, E. Y. DENKERS, S. HIENY, P. CASPAR, G. TRINCHIERI, AND A. SHER. 1994. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. Journal of Immunology 153: 2533-2543.
22. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. Journal of Immunology 149: 175-180.
23. HUNTER, C. A., C. W. ROBERTS, AND J. ALEXANDER. 1992. Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis. European Journal of Immunology 22: 2317-2322.
24. KANG, H., J. S. REMINGTON, AND Y. SUZUKI. 2000. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-γ, TNF-α, and inducible nitric oxide synthase. Journal of Immunology 164: 2629-2634.
25. KHAN, I. A., J. A. MACLEAN, E S. LEC, L. CASCIOTTI, E. DEHAAN, J. D. SCHWARTZMAN, AND A. D. LUSTER. 2000. IP-10 is crucial for effector T cell trafficking and host survival in Toxoplasma gondii. Infection and Immunity 12: 483-494.
26. -, P. M. MURPHY, L. CASCIOTTI, J. D. SCHWARTZMAN, J. COLLINS, J. L. GAO, AND G. R. YEAMAN. 2001. Mice lacking the chemokine receptor CCR1 show increased susceptibility to Toxoplasma gondii infection. Journal of Immunology 166: 1930-1937.
27. -, S. Y. THOMAS, M. M. MORETTO, F. S. LEE, S. A. ISLAM, C. COMBE, J. D. SCHWARTZMAN, AND A. D. LUSTER. 2006. CCR5 is essential for NK cell trafficking and host survival following Toxo plasma gondii infection. Public Library of Science Pathogens 2: 49-55.
28. KIM, S. K., AND J. C. BOOTHROYD. 2005. Stage-specific expression of surface antigens by Toxoplasma gondii as a mechanism to facilitate parasite persistence. Journal of Immunology 174: 8038-8048.
29. LIEBERMAN, L. A., AND C. A. HUNTER. 2002. The role of cytokines and their signaling pathways in the regulation of immunity to Toxoplasma gondii. International Review of Immunology 21: 373-403.
30. + T cell-dependent, interferon-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. Journal of Experimental Medicine 184: 597-609.
31. MONTOYA, J., AND O. LIESENFELD. 2004. Toxoplasmosis. Lancet 363: 1965-1976.
32. MULLARKY, I., F. SZABA, K. BERGGREN, L. KUMMER, L. WILHELM, M. PARENT, L. JOHNSON, AND S. SMILEY. 2006. Tumor necrosis factor alpha and gamma interferon, but not hemorrhage or pathogen burden, dictate levels of protective fibrin deposition during infection. Infection and Immunity 74: 1181-1188.
33. MURDOCH, C., AND A. FINN. 2000. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95: 3032-3043.
34. PFEFFERKORN, E. R. 1984. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proceedings of National Academy Sciences USA 81: 908-912.
35. + monocytes is essential for control of acute toxoplasmosis. Journal of Experimental Medicine 201: 1761-1769.
36. SCHARTON-KERSTEN, T M., T. A. WYNN, E. Y. DENKERS, S. BALA, E. GRUNVALD, S. HIENY, R. T. GAZZINELLI, AND A. SHER. 1996. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. Journal of Immunology 157: 4045-4054.
37. SCHLÜTER, D., J. LOHLER, M. DECKERT, H. HOF, AND G. SCHWENDEMANN. 1991. Toxoplasma encephalitis of immunocompetent and nude mice: Immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility complex gene products. Journal of Neuroimmunology 31: 185-198.
38. STRACK, A., V. C. ASENSIO, I. L. CAMPBELL, D. SCHLÜTER, AND M. DECKERT. 2002. Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma. Acta Neuropathologica (Berlin) 103: 458-468.
39. -, D. SCHLÜTER, V. C. ASENSIO, I. L. CAMPBELL, AND M. DECKERT. 2002. Regulation of the kinetics of intracerebral chemokine gene expression in murine Toxoplasma encephalitis: Impact of host genetic factors. Glia 40: 372-377.
40. SUZUKI, Y. 2002. Immunopathogenesis of cerebral toxoplasmosis. Journal of Infectious Diseases 186: S234-S240.
41. -, K. JOH, M. A. ORELLANA, F. K. CONLEY, AND J. S. REMINGTON. 1991. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 74: 732-739.
42. -, M. A. ORELLANA, R. SCHREIBER, AND J. S. REMINGTON. 1988. Interferon-γ: The major mediator of resistance against Toxoplasma gondii. Science 240: 516-518.
43. UBOGU, E. E., M. B. COSSOY, AND R. M. RANSOHOFF. 2006. The expression and function of chemokines involved in CNS inflammation. Trends in Pharmacological Sciences 27: 63-68.
44. VAN DUIN, D., R. MEDZHITOV, AND A. SHAW. 2006. Triggering TLR signaling in vaccination. Trends in Immunology 27: 49-55.
45. WILSON, E., AND C. HUNTER. 2004. The role of astrocytes in the immunopathogenesis of toxoplasmic encephalitis. International Journal for Parasitology 34: 543-548.
46. YAP, G., AND A. SHER. 1999. Cell mediated immunity to Toxoplasma gondii: Initiation, regulation and effector function. Immunobiology 201: 240-247.